Srs Capital Advisors, Inc. Procept Bio Robotics Corp Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 42 shares of PRCT stock, worth $2,501. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42
Previous 43
2.33%
Holding current value
$2,501
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$306 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$208 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$104 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$88.8 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$71.9 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.66B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...